| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2544402 | Journal of the American Pharmacists Association | 2006 | 11 Pages |
Abstract
This blinded study determined methods to identify acceptable agents and provided results, which, in addition to regulatory compliance supplier audits, formed the basis for chondroitin product selection in GAIT.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Barnhill PhD, Fye BPharm, MS, Williams MS, Reda PhD, Clegg MD, Harris PharmD,